Syntheses of two potential food mutagens

Journal of Heterocyclic Chemistry

Volumn 40, Issue 4, 2003, Pages 569-573

  Tanga, M J ^a   Bradford, W W ^a   Bupp, J E ^a   Kozocas, J A ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,6 TRIMETHYL 2 AMINOIMIDAZO[4,5 C]PYRIDINE; 1,5,7 TRIMETHYL 2 AMINOIMIDAZO[4,5 B]PYRIDINE; HETEROCYCLIC AMINE; IMIDAZO[4,5 B]PYRIDINE DERIVATIVE; IMIDAZO[4,5 C]PYRIDINE DERIVATIVE; MUTAGENIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CHEMICAL REACTION; COOKING; DIET; FOOD; NUTRITION; SYNTHESIS;

EID: 0141619330     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570400403     Document Type: Article

References (21)

1. D. W. Layton, K. T. Bogen, M. G. Knize, F. T. Hatch, V. M. Johnson, and J. S. Felton, Carcinogenesis, 16, 39 (1995).
2. E T. Hatch, M. G. Knize, S. K. Healy, T. Slezak, and J. S. Felton, Environ. Mol. Mutagen., 12, 1 (1988).
3. S. Robbana-Barrat, M. Rabache, E. Rialland, and J. Fradin, Environ. Health Perspect., 104, 280 (1996).
4. K. Skog, G. Steineck, K. Augustsson, and M. Jägerstad, Carcinogenesis, 16, 861 (1995).
5. C. P. Salmon, M. G. Knize, and J. S. Felton, Food Chem. Toxicol. 35, 433 (1997).
6. A. Oguri, M. Suda, Y. Totsuka, T. Sugimura, and K. Wakabayashi, Mutat. Res. 402, 237 (1998).
7. R. H. Dashwood, M. Xu, J. F. Hernaez, N. Hasaniya, K. Youn, and A. Razzuk, Proc. Soc. Exp. Biol. Med. 220, 239 (1999).
8. J. D. Felton, M. G. Knize, C. Wood, B. J. Wuebbles, S. K. Healy, D. H. Struermer, L. F. Bjeldfanes. B. J. Kimble, and F. T. Hatch, Carcinogenesis, 5, 95 (1984).
9. T. Sugimura, S. Sato, and K. Wakabayashi, Chemical Induction of Cancer, Structural Bases and Biological Mechanisms, Y. T. Woo, D. Y. Lai, J. C. Arcos, and M. F. Argus, eds., Academic Press, New York, 1988, p. 681.
10. IRAC Monographs on the Evaluation of Carcinogenic Risks to Humans. No. 56, Some Naturally Occurring Substances: Food Items and Constituents. Heterocyclic Aromatic Amines and Mycotoxins, International Agency for Research on Cancer, Lyon, France, 1993, p. 165.
11. G. A. Keating, D. W. Layton, and J. S. Felton, Mutation Res., 443, 149 (1999).
12. W. Zheng, D. R. Gustafson, R. Sinha, J. R. Cerhan, D. Moore, C. P. Hong, K. E. Anderson, L. H. Kushi, T. A. Sellers, and A. R. Folsom, J. Natl. Cancer Inst. 90, 1687 (1998).
13. K. H. Dingley, K. D. Curtis, S. Nowell, J. S. Felton, N. P. Land, and K. W. Turteltaub, Cancer Epidemiol. Biomarkers Prevention 8, 507 (1999).
14. J. S. Felton, M. G. Knize, N. H. Shen, B. D. Andersen, L. F. Bjeldanes, and F. T. Hatch, Environ. Health Perspect., 67, 17 (1986).
15. J. S. Felton, M. G. Knize, M. Roper, E. Fultz, N. H. Shen, and K. W. Turteltaub, Cancer Res., 52 (Suppl.), 2103 (1992).
16. G. Becher, M. G. Knize, I. F. Nes, and J. S. Felton, Carcinogenesis, 9, 247 (1988).
17. J. S. Felton,M. G. Knize, F. T. Hatch,M. J. Tanga, and M. E. Colvin, Cancer Lett., 143, 127 (1999).
18. M. J. Tanga, J. E. Bupp, and T. K. Tochimoto, J. Heterocyclic Chem., 31, 1641 (1994).
19. M. J. Tanga, J. E. Bupp, and T. K. Tochimoto, J. Heterocyclic Chem., 34, 717 (1997).
20. The ten isomers 1,5,6-trimethyl-2-aminoimidazo[4,5-b]pyridine; 3,5,6-trimethyl-2-aminoimidazo[4,5-b]pyridine; 3,5,7trimethyl-2-aminoimidazo[4,5-b]pyridine; 1,4,7-trimethyl-2-aminoimidazo [4,5-c]pyridine; 1,6,7-trimethyl-2-aminoimidazo[4,5-c]pyridine; 3,4,6-trimethyl-2-aminoimidazo[4,5-c]pyridine; 1,4,6-trimethyl-2-aminoimidazo[4,5-c]pyridine; 1,5,7-trimethyl-2-aminoimidazo[4,5-b]pyridine; 3,6,7-trimethyl-2-aminoimidazo[4,5-b]pyridine; and 3,6,7-trimethyl-2-aminoimidazo[4,5-c]pyridine are presently available as reference materials from Dr. Harold Seifried, National Cancer Institute, 6130 Executive Boulevard, EPN 3158, Bethesda, MD 20852.
21. R. Gompper and R. Kunz, Chem, Ber., 99, 2900 (1966).